coumarin has been researched along with Idiopathic Parkinson Disease in 4 studies
2H-chromen-2-one: coumarin derivative
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, H | 1 |
| Maeng, HJ | 1 |
| Kim, JH | 1 |
| Yoon, JH | 1 |
| Oh, Y | 1 |
| Paek, SM | 1 |
| Lee, Y | 1 |
| Rodríguez-Enríquez, F | 1 |
| Costas-Lago, MC | 1 |
| Besada, P | 1 |
| Alonso-Pena, M | 1 |
| Torres-Terán, I | 1 |
| Viña, D | 1 |
| Fontenla, JÁ | 1 |
| Sturlese, M | 1 |
| Moro, S | 1 |
| Quezada, E | 1 |
| Terán, C | 1 |
| Fernandes, C | 1 |
| Martins, C | 1 |
| Fonseca, A | 1 |
| Nunes, R | 1 |
| Matos, MJ | 1 |
| Silva, R | 1 |
| Garrido, J | 1 |
| Sarmento, B | 1 |
| Remião, F | 1 |
| Otero-Espinar, FJ | 1 |
| Uriarte, E | 1 |
| Borges, F | 1 |
| Yap, AC | 1 |
| Mahamad, UA | 1 |
| Lim, SY | 1 |
| Kim, HJ | 1 |
| Choo, YM | 1 |
4 other studies available for coumarin and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
Synthetic Peucedanocoumarin IV Prevents α-Synuclein Neurotoxicity in an Animal Model of Parkinson's Disease.
Topics: alpha-Synuclein; Animals; Coumarins; Disease Models, Animal; Dopaminergic Neurons; Mice; Parkinson D | 2022 |
Novel coumarin-pyridazine hybrids as selective MAO-B inhibitors for the Parkinson's disease therapy.
Topics: Animals; Coumarins; Dose-Response Relationship, Drug; Humans; Injections, Intraperitoneal; Male; Mic | 2020 |
PEGylated PLGA Nanoparticles As a Smart Carrier to Increase the Cellular Uptake of a Coumarin-Based Monoamine Oxidase B Inhibitor.
Topics: Caco-2 Cells; Cell Line, Tumor; Coumarins; Drug Carriers; Humans; Inhibitory Concentration 50; Micro | 2018 |
A coumarin-based fluorescent probe as a central nervous system disease biomarker.
Topics: Biomarkers; Biosensing Techniques; Coumarins; Fluorescent Dyes; Homocysteine; Humans; Methylmalonic | 2014 |